Gland Pharma Limited

NSEI:GLAND 주식 보고서

시가총액: ₹298.3b

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Gland Pharma 관리

관리 기준 확인 2/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Srinivas Sadu

최고 경영자

₹123.6m

총 보상

CEO 급여 비율49.2%
CEO 임기5.3yrs
CEO 소유권n/a
경영진 평균 재임 기간less than a year
이사회 평균 재임 기간4.5yrs

최근 관리 업데이트

Recent updates

Does Gland Pharma (NSE:GLAND) Have A Healthy Balance Sheet?

Jun 22
Does Gland Pharma (NSE:GLAND) Have A Healthy Balance Sheet?

Earnings Miss: Gland Pharma Limited Missed EPS By 15% And Analysts Are Revising Their Forecasts

May 25
Earnings Miss: Gland Pharma Limited Missed EPS By 15% And Analysts Are Revising Their Forecasts

Is Gland Pharma (NSE:GLAND) A Risky Investment?

Mar 19
Is Gland Pharma (NSE:GLAND) A Risky Investment?

Gland Pharma Limited's (NSE:GLAND) Share Price Matching Investor Opinion

Feb 16
Gland Pharma Limited's (NSE:GLAND) Share Price Matching Investor Opinion

Analysts' Revenue Estimates For Gland Pharma Limited (NSE:GLAND) Are Surging Higher

May 20
Analysts' Revenue Estimates For Gland Pharma Limited (NSE:GLAND) Are Surging Higher

Is Gland Pharma Limited (NSE:GLAND) Expensive For A Reason? A Look At Its Intrinsic Value

Feb 07
Is Gland Pharma Limited (NSE:GLAND) Expensive For A Reason? A Look At Its Intrinsic Value

Analysts Just Slashed Their Gland Pharma Limited (NSE:GLAND) EPS Numbers

Jul 22
Analysts Just Slashed Their Gland Pharma Limited (NSE:GLAND) EPS Numbers

Does This Valuation Of Gland Pharma Limited (NSE:GLAND) Imply Investors Are Overpaying?

Jul 14
Does This Valuation Of Gland Pharma Limited (NSE:GLAND) Imply Investors Are Overpaying?

Is Now The Time To Put Gland Pharma (NSE:GLAND) On Your Watchlist?

Feb 08
Is Now The Time To Put Gland Pharma (NSE:GLAND) On Your Watchlist?

A Look At The Intrinsic Value Of Gland Pharma Limited (NSE:GLAND)

Jul 05
A Look At The Intrinsic Value Of Gland Pharma Limited (NSE:GLAND)

Gland Pharma (NSE:GLAND) Strong Profits May Be Masking Some Underlying Issues

May 24
Gland Pharma (NSE:GLAND) Strong Profits May Be Masking Some Underlying Issues

Gland Pharma Limited (NSE:GLAND) Exceeded Expectations And The Analyst Consensus Has Been Reviewing Its Models

May 19
Gland Pharma Limited (NSE:GLAND) Exceeded Expectations And The Analyst Consensus Has Been Reviewing Its Models

Gland Pharma Limited's (NSE:GLAND) 27% Price Boost Is Out Of Tune With Earnings

Mar 04
Gland Pharma Limited's (NSE:GLAND) 27% Price Boost Is Out Of Tune With Earnings

Gland Pharma Limited's (NSE:GLAND) Stock Is Going Strong: Is the Market Following Fundamentals?

Feb 20
Gland Pharma Limited's (NSE:GLAND) Stock Is Going Strong: Is the Market Following Fundamentals?

CEO 보상 분석

Srinivas Sadu 의 보수는 Gland Pharma 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Mar 31 2024n/an/a

₹8b

Dec 31 2023n/an/a

₹7b

Sep 30 2023n/an/a

₹7b

Jun 30 2023n/an/a

₹7b

Mar 31 2023₹124m₹61m

₹8b

Dec 31 2022n/an/a

₹10b

Sep 30 2022n/an/a

₹10b

Jun 30 2022n/an/a

₹11b

Mar 31 2022₹124m₹61m

₹12b

Dec 31 2021n/an/a

₹12b

Sep 30 2021n/an/a

₹11b

Jun 30 2021n/an/a

₹10b

Mar 31 2021₹89m₹31m

₹10b

Dec 31 2020n/an/a

₹9b

Jun 30 2020n/an/a

₹9b

Mar 31 2020₹59m₹32m

₹8b

Mar 31 2019₹23mn/a

₹5b

Mar 31 2018₹11m₹5m

₹3b

보상 대 시장: Srinivas 의 총 보상 ($USD 1.48M )은 Indian 시장( $USD 544.21K ).

보상과 수익: Srinivas 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.

CEO

Srinivas Sadu (55 yo)

5.3yrs

테뉴어

₹123,580,000

보상

Mr. Srinivas Sadu, B. Pharm, M. S., MBA, PG Certificate in Finance and Management, has been Managing Director, Executive Director and Chief Executive Officer at Gland Pharma Ltd. since April 25, 2019 and s...

리더십 팀

이름위치테뉴어보상소유권
Srinivas Sadu
MD, CEO & Executive Chairman5.3yrs₹123.58m데이터 없음
Ravi Mitra
Chief Financial Officer4.8yrs₹15.15m데이터 없음
Sampath Pallerlamudi
Company Secretary & Vice-President of Compliance & CSRno data₹5.11m데이터 없음
Satnam Loomba
Chief Operating Officerless than a year데이터 없음데이터 없음
Ankit Gupta
Head of Investmentsless than a year데이터 없음데이터 없음
Surinder Koul
Head of Domestic Marketingless than a year데이터 없음데이터 없음
Shilpi Sahay
Deputy General Manager of Human Resourcesno data데이터 없음데이터 없음
C. Venkatesan
Senior Vice President of R&Dno data₹11.35m0%
₹ 0
Surapanini Sridevi
Senior Vice President of R&Dno data데이터 없음데이터 없음
K Rao
Head of Qualityless than a year데이터 없음0.0012%
₹ 3.7m
Rong Wu
Chief Financial Controllerno data데이터 없음0.0073%
₹ 21.7m

0.6yrs

평균 재임 기간

53yo

평균 연령

경험이 풍부한 관리: GLAND 의 관리팀은 경험 (평균 재직 기간 0.5 년)으로 간주되지 않으므로 새로운 팀을 추천합니다.

이사회 구성원

이름위치테뉴어보상소유권
Srinivas Sadu
MD, CEO & Executive Chairman5.3yrs₹123.58m데이터 없음
Fang Yao
Non-Executive & Non- Independent Director2.3yrs데이터 없음데이터 없음
Naina Lal Kidwai
Independent Director3.2yrs₹10.40m데이터 없음
Udo Vetter
Independent Director6.4yrs₹2.90m데이터 없음
Jia Ai Zhang
Non-Independent Non Executive Director3.2yrs데이터 없음데이터 없음
Satyanarayana Chavali
Independent Director5.7yrs₹3.00m데이터 없음
Chen Qiyu
Non-Executive & Non-Independent Director6.8yrs데이터 없음데이터 없음
Essaji Vahanvati
Independent Director3.8yrs₹2.90m데이터 없음

4.5yrs

평균 재임 기간

60yo

평균 연령

경험이 풍부한 이사회: GLAND 의 이사회는 경험(평균 재직 기간 4.5 년)으로 간주됩니다.